A phase I dose escalation trial of vaccine replicon particles (VRP) expressing prostate-specific membrane antigen (PSMA) in subjects with prostate cancer - ScienceDirect
Increased sensitivity to detect vRNA by the next-generation RNAscope... | Download Scientific Diagram